Coronavirus vaccines developed in China could be ready for use by the general public as early as November, an official from the Chinese Center for Disease Control and Prevention (CDC) said.
China has four COVID-19 vaccines in the final stages of clinical trials. At least three of these have already been offered to key workers as part of an emergency program launched in July.
Phase 3 clinical trials have been going smoothly and the vaccines could be ready for the general public by November or December, CDC chief biosafety expert Guizhen Wu said in an interview with state television late Monday.
Wu, who said she had not experienced any abnormal symptoms in the past few months after taking an experimental vaccine herself in April, did not disclose which vaccines she was referring to.
A unit of the state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and the US-listed Sinovac Biotech are developing the three vaccines as part of the state emergency program. A fourth COVID-19 vaccine developed by CanSino Biologics was approved for use by the Chinese military in June.
Sinopharm said in July that its vaccine could be ready for public use upon completion of Phase 3 trials by the end of this year.
Global vaccine manufacturers are working hard to develop an effective vaccine against the virus, which has killed more than 925,000 people. Leading Western vaccine manufacturers committed earlier this month to upholding standards for scientific studies and rejecting any political pressure to accelerate the process.
(This story was not edited by GossipMantri staff and is automatically generated from a syndicated feed.)